[go: up one dir, main page]

PT2049480E - Derivados de 2-arilindole como inibidores da mpges-i - Google Patents

Derivados de 2-arilindole como inibidores da mpges-i

Info

Publication number
PT2049480E
PT2049480E PT77867406T PT07786740T PT2049480E PT 2049480 E PT2049480 E PT 2049480E PT 77867406 T PT77867406 T PT 77867406T PT 07786740 T PT07786740 T PT 07786740T PT 2049480 E PT2049480 E PT 2049480E
Authority
PT
Portugal
Prior art keywords
mpges
inhibitors
arylindole
arylindole derivatives
derivatives
Prior art date
Application number
PT77867406T
Other languages
English (en)
Inventor
Angelo Guglielmotti
Lorenzo Polenzani
Nicola Cazzolla
Guido Furlotti
Maria Alessandra Alisi
Giorgina Mangano
Isabella Coletta
Caterina Maugeri
Barbara Garofalo
Beatrice Garrone
Rosella Ombrato
Original Assignee
Acraf
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Acraf filed Critical Acraf
Publication of PT2049480E publication Critical patent/PT2049480E/pt

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D209/00Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04Indoles; Hydrogenated indoles
    • C07D209/08Indoles; Hydrogenated indoles with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, directly attached to carbon atoms of the hetero ring
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/08Vasodilators for multiple indications
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D209/00Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04Indoles; Hydrogenated indoles
    • C07D209/10Indoles; Hydrogenated indoles with substituted hydrocarbon radicals attached to carbon atoms of the hetero ring
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D209/00Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04Indoles; Hydrogenated indoles
    • C07D209/10Indoles; Hydrogenated indoles with substituted hydrocarbon radicals attached to carbon atoms of the hetero ring
    • C07D209/12Radicals substituted by oxygen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Rheumatology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pain & Pain Management (AREA)
  • Immunology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Indole Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
PT77867406T 2006-07-14 2007-06-14 Derivados de 2-arilindole como inibidores da mpges-i PT2049480E (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT001368A ITMI20061368A1 (it) 2006-07-14 2006-07-14 Composto 2-arilindolico sostituito in posizione 5, composizione farmaceutica che lo comprende nonche' composti intermedi e procedimento per prepararlo

Publications (1)

Publication Number Publication Date
PT2049480E true PT2049480E (pt) 2013-12-16

Family

ID=37895798

Family Applications (1)

Application Number Title Priority Date Filing Date
PT77867406T PT2049480E (pt) 2006-07-14 2007-06-14 Derivados de 2-arilindole como inibidores da mpges-i

Country Status (22)

Country Link
US (1) US8017644B2 (pt)
EP (1) EP2049480B1 (pt)
JP (1) JP5302191B2 (pt)
KR (2) KR20140091569A (pt)
CN (1) CN101490000B (pt)
AR (1) AR061973A1 (pt)
AU (1) AU2007271865B2 (pt)
BR (1) BRPI0712889A8 (pt)
CA (1) CA2655750C (pt)
DK (1) DK2049480T3 (pt)
EA (1) EA015689B1 (pt)
ES (1) ES2441594T3 (pt)
GE (1) GEP20115166B (pt)
HK (1) HK1124068A1 (pt)
IL (1) IL196000A (pt)
IT (1) ITMI20061368A1 (pt)
MX (1) MX2009000492A (pt)
PL (1) PL2049480T3 (pt)
PT (1) PT2049480E (pt)
SI (1) SI2049480T1 (pt)
UA (1) UA96759C2 (pt)
WO (1) WO2008006663A1 (pt)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2078711A1 (en) * 2007-12-28 2009-07-15 AZIENDE CHIMICHE RIUNITE ANGELINI FRANCESCO A.C.R.A.F. S.p.A. (Aza)indole derivative substituted in position 5, pharmaceutical composition comprising it, intermediate compounds and preparation process therefor
AU2010232729A1 (en) 2009-03-31 2011-10-20 Arqule, Inc. Substituted indolo-pyridinone compounds
WO2011077313A1 (en) 2009-12-22 2011-06-30 Pfizer Inc. Piperidinecarboxamides as mpges - 1 inhibitors
UA108950C2 (uk) * 2011-08-18 2015-06-25 Гетероциклічна похідна і фармацевтичний засіб
WO2013038308A1 (en) * 2011-09-15 2013-03-21 Glenmark Pharmaceuticals S.A. SUBSTITUTED BICYCLIC HETEROARYL COMPOUNDS AS mPGES-1 INHIBITORS
CN105636951B (zh) 2014-04-14 2018-05-15 上海恒瑞医药有限公司 酰胺类衍生物及其可药用盐、其制备方法及其在医药上的应用
CN107001267A (zh) * 2014-08-08 2017-08-01 马合伙人株式会社 稠合杂环化合物
CN112074505B (zh) 2018-03-08 2024-04-05 因赛特公司 作为PI3K-γ抑制剂的氨基吡嗪二醇化合物
US11046658B2 (en) 2018-07-02 2021-06-29 Incyte Corporation Aminopyrazine derivatives as PI3K-γ inhibitors
US20230000821A1 (en) * 2019-08-26 2023-01-05 Kukje Pharma Co., Ltd. Indole carboxamide derivative and pharmaceutical composition containing same
KR20230010236A (ko) 2020-05-12 2023-01-18 피엠브이 파마슈티컬스 인코포레이티드 돌연변이 p53 기능을 회복시키기 위한 방법 및 화합물

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2003270426A1 (en) * 2002-09-12 2004-04-30 Avanir Pharmaceuticals PHENYL-INDOLE COMPOUNDS FOR MODULATING IgE AND INHIBITING CELLULAR PROLIFERATION
PL378119A1 (pl) * 2003-02-07 2006-03-06 Ono Pharmaceutical Co., Ltd. Kwasy karboksylowe
OA13247A (en) 2003-09-03 2007-01-31 Pfizer Phenyl or pyridyl amide coumpounds as prostaglandin E2 antagonists.
ITTO20040125A1 (it) * 2004-03-01 2004-06-01 Rotta Research Lab Nuove amidine eterocicliche inibitrici la produzione di ossido d'azoto (no) ad attivita' antinfiammatoria ed analgesica
GB0410121D0 (en) 2004-05-06 2004-06-09 Glaxo Group Ltd Compounds

Also Published As

Publication number Publication date
DK2049480T3 (da) 2014-01-20
PL2049480T3 (pl) 2014-03-31
JP5302191B2 (ja) 2013-10-02
EA015689B1 (ru) 2011-10-31
EA200970124A1 (ru) 2009-06-30
SI2049480T1 (sl) 2014-02-28
AU2007271865B2 (en) 2013-02-21
MX2009000492A (es) 2009-01-27
KR20140091569A (ko) 2014-07-21
GEP20115166B (en) 2011-02-25
ITMI20061368A1 (it) 2008-01-15
IL196000A0 (en) 2009-09-01
JP2009543766A (ja) 2009-12-10
IL196000A (en) 2013-10-31
EP2049480A1 (en) 2009-04-22
US8017644B2 (en) 2011-09-13
AR061973A1 (es) 2008-08-10
CN101490000B (zh) 2012-10-03
CN101490000A (zh) 2009-07-22
BRPI0712889A8 (pt) 2018-01-02
ES2441594T3 (es) 2014-02-05
KR101440015B1 (ko) 2014-09-12
HK1124068A1 (en) 2009-08-07
WO2008006663A1 (en) 2008-01-17
BRPI0712889A2 (pt) 2012-10-09
CA2655750A1 (en) 2008-01-17
EP2049480B1 (en) 2013-10-30
AU2007271865A1 (en) 2008-01-17
CA2655750C (en) 2014-09-09
KR20090054962A (ko) 2009-06-01
US20090186922A1 (en) 2009-07-23
UA96759C2 (en) 2011-12-12

Similar Documents

Publication Publication Date Title
PT2049480E (pt) Derivados de 2-arilindole como inibidores da mpges-i
UA94833C2 (en) Substituted bicyclolactams
WO2007148185A3 (en) Substituted 3 -amino- pyrrolidino-4 -lactams as dpp inhibitors
MY148634A (en) Pyridazinone derivatives
MY149512A (en) Pyrazolylaminopyridine derivatives useful as kinase inhibitors
WO2006123113A3 (en) Pyrazolylaminopyrimidine derivatives useful as tyrosine kinase inhibitors
MX2010003155A (es) Derivados de ciclopropil aril amida y uso de los mismos.
CY1113011T1 (el) Νεα κρυσταλλικη μορφη v της αγομελατινης, μεθοδος παρασκευης αυτης και φαρμακευτικες συνθεσεις που περιεχουν αυτην
TW200745066A (en) Novel PTP1B inhibitors
SG154433A1 (en) Phthalazine derivatives as parp inhibitors
TW200745084A (en) Novel compounds
GEP20125547B (en) (aza) indole derivative substituted in position 5, pharmaceutical composition comprising it, intermediate compounds and preparation process therefor
WO2006116733A3 (en) Protein kinase inhibitors
SE0400284D0 (sv) Novel compounds
IL173810A0 (en) Imidazopyridine derivatives and pharmaceutical compositions containing the same
TW200639156A (en) New compounds
TW200702330A (en) 3,4,5-Substituted piperidines
NO20064351L (no) Caspaseinhibitorer og anvendelser derav
TW200714598A (en) Urea derivatives, methods for their manufacture, and uses therefor
WO2007017728A3 (en) Novel heterocyclic compounds
MX2010003060A (es) Inhibidores de la interaccion entre mdm2 y p53.
WO2009105969A8 (zh) 埃坡霉素类似物、其药物组合物、用途及其制备方法
TW200603799A (en) Selected CGRP-antagonists, process for preparing them and their use as pharmaceutical compositions
DE602004008959D1 (de) Benzoäbüä1,4üdioxepinderivate
MX2009006334A (es) Derivados de heteroaril-pirrolidinil- y -piperidinil-cetona.